World Aging & Longevity Conference
October 08-10, 2026
Sarcopenia
Sarcopenia is a progressive age associated condition characterized by loss of skeletal muscle mass, strength, and functional performance. It arises from muscle fiber atrophy, reduced protein synthesis, impaired neuromuscular signaling, and chronic inflammation. Declining anabolic signaling, hormonal changes, and reduced physical activity accelerate muscle deterioration. Sarcopenia increases risk of falls, mobility limitation, disability, and loss of independence. It also affects metabolic regulation by reducing glucose uptake and insulin sensitivity. Sarcopenia is a major contributor to frailty and reduced quality of life in older adults. Early recognition of sarcopenia enables interventions aimed at preserving muscle strength and functional capacity. Understanding sarcopenia is essential for addressing physical decline associated with aging.
Kenneth R Pelletier
University of California School of Medicine, United States
Thomas J Webster
Brown University, United States
Jason Beckwith
BioTalent, United Kingdom
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Jose Cordeiro Mateo
International Longevity Summit, Spain
Ashot Khachatryan
National Academy of Sciences of the Republic of Armenia, Armenia
Utpol Das
University of Texas Medical Branch at Galveston, United StatesSubmit your abstract Today
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom